Health official under probe following GSK scandal2013-12-10
Huang Fengping, deputy director of the Shanghai Municipal Commission of Health and Family Planning, is said to have been suspended following an investigation into his alleged involvement in economic crimes related to British pharmaceutical and healthcare giant GlaxoSmithKline (GSK).

China might charge some local GSK execs: report2013-11-05
Chinese police investigating allegations of widespread corrupt practices at GlaxoSmithKline Plc(GSK)are likely to charge some of its Chinese executives but not the British drug maker itself, Reuters reported Monday, citing legal and industry sources.

Official responds over imported medicine pricing2013-09-08
A Chinese official has cited tax, additional pricing by hospitals and bloated circulation fees as the cause of high-end imported medicine to be sold at higher prices on the mainland than in Hong Kong.

Police reveals more about GSK China's violations2013-09-03
The Chinese police have recently revealed more details about suspected economic violations by GlaxoSmithKline (GSK) China.

China to launch fresh pharm bribery probe2013-08-15
China is intensifying its investigation into rampant bribery in the pharmaceu tical and medical services sector with a fresh three-month probe slated to begin on Thursday, the official Xinhua news agency reported.

Health authorities probe bribes to doctors2013-08-12
Health authorities have started to probe the alleged 1.69 million yuan ($276,000) in bribes from Sanofi-Aventis to 503 doctors in Beijing, Shanghai, Hangzhou and Guangzhou.

Probes not targeting foreign brands2013-08-07
Ministry of Commerce spokesman Shen Danyang said it is groundless to imply that China's recent investigation into the healthcare industry, including probes into GlaxoSmithKline, Sanofi and Eli Lilly, have targeted foreign brands.

Clamping down on corporate bribery2013-07-30
British drug maker GlaxoSmithKline (GSK) has been mired in allegations of corruption in China recently.

Police reveal details of GSK China's alleged violations2013-07-26
The Chinese police on Thursday revealed details of GlaxoSmithKline(GSK)China's alleged bribery and tax-related violations that pushed up drug prices and disrupted market order.

Pricing investigation2013-07-24
Media reported on Tuesday that the National Development and Reform Commission has launched an investigation into 60 drugmakers, including foreign companies and more than 10 listed domestic companies.

China tightening regulation of pharmaceutical sector2013-07-23
Spokesman for the Belgian drug maker UCB has admitted that the company's Shanghai office is being investigated by China's State Administration of Industry and Commerce, the country's market watchdog. It's the second such investigation into an overseas drug maker in China. UCB's Spokesperson has said other pharmaceutical companies operating in China are also under investigation.

Chinese police question employee of AstraZeneca2013-07-23
Chinese police have visited the Shanghai office of British drugmaker AstraZeneca, the latest foreign firm to be investigated following allegations against GlaxoSmithKline(GSK).

Police get drug giant's help in bribery scandal2013-07-23
British pharmaceutical giant GlaxoSmithKline promised to cooperate with Chinese police in the investigation of an alleged bribery and drug pricing scandal after a representative of the head office met with a senior official from the Ministry of Public Security.

Chinese official meets GSK representative2013-07-22
A senior official from the Ministry of Public Security(MPS)has met with a representative from the head office of pharmaceu tical giant GlaxoSmithKline(GSK), urging the company to cooperate with the Chinese police in investigations.